CION Ameerpet
A lymph node biopsy is the test that confirms lymphoma and names the exact subtype. This guide explains why lymphoma usually needs the whole node removed, how the procedure works, recovery, and how long results take — and how CION's team handles it all.
A lymph node biopsy is the procedure that removes a lymph node — or part of one — so a pathologist can examine it and confirm whether lymphoma is present. It is the definitive test for diagnosis: scans and blood tests can raise suspicion, but only tissue can confirm lymphoma and reveal which of its many subtypes you have. If you have been told a swollen node needs sampling, or a node has been found on a scan, this is the step that turns uncertainty into a clear diagnosis.
The most important thing to understand about a biopsy for lymphoma is that lymphoma is diagnosed from the architecture of the node — the way cells are arranged, not just how individual cells look. That is why doctors prefer to remove the whole node rather than take a small needle sample. This whole-node (excisional) approach gives the pathologist the full picture and avoids the risk of an inconclusive result.
This guide walks through the node biopsy procedure step by step: how it is done, what recovery is like, how long results take, and the tissue tests that follow. For the wider picture, see our Lymphoma hub and, once you have a diagnosis, our Lymphoma Treatment in Hyderabad page.
For suspected lymphoma, NCCN and ESMO guidelines recommend an excisional (whole-node) biopsy rather than a fine-needle aspiration wherever a node is accessible. That is because lymphoma is diagnosed largely from the intact architecture of the lymph node — how the cells are organised — which a needle sample of loose cells cannot reliably show. Removing the whole node the first time reduces the chance of a non-diagnostic result and a repeat procedure. (Source: NCCN and ESMO clinical practice guidelines for Hodgkin and non-Hodgkin lymphoma.)
Not all biopsies are equal for lymphoma. The method chosen depends on where the enlarged node sits and how much tissue is needed to reach a confident diagnosis.
The preferred method for lymphoma. The surgeon removes an entire lymph node, preserving its architecture so the pathologist can see the full pattern. Best for accessible nodes in the neck, armpit or groin. Read why the whole node matters versus an FNA.
Uses a hollow needle, often under ultrasound or CT guidance, to take one or more tissue cores. A reasonable alternative when a node is deep or surgery is not practical. Learn more about the core needle biopsy for lymphoma and when it is enough.
Draws out loose cells with a thin needle. Useful for some conditions, but generally not adequate to diagnose lymphoma on its own, because it loses the node's architecture. It may be a first step to rule out other causes before a proper tissue biopsy.
Not a substitute for a node biopsy, but often done alongside it during staging to see whether lymphoma involves the marrow. See bone marrow biopsy in lymphoma — why and how.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you are waiting for a biopsy, waiting for results, or want a second look at a pathology report, CION's haematology and lymphoma team is here to guide you.
Knowing what happens on the day takes a lot of the worry out of a biopsy. For an accessible surface node, an excisional biopsy is usually a short day-care procedure; deeper nodes may need an image-guided approach. Here is the typical pathway:
You will have blood tests and a review of your medications — particularly blood thinners, which may need to be paused. Imaging helps the team choose the most informative node to remove, not simply the easiest one. You will be told whether local or general anaesthetic is planned, and whether you need to fast beforehand.
For an excisional biopsy, the area is numbed with local anaesthetic and sedation, or you are asleep under general anaesthetic. The surgeon makes a small incision, removes the whole node, and closes with fine sutures. It usually takes 30 to 60 minutes. For a deep node in the chest or abdomen, an image-guided core needle biopsy under CT or ultrasound is used instead. The tissue is sent fresh to the laboratory so that flow cytometry and molecular studies can be run alongside standard staining.
Most people go home the same day. Mild soreness, bruising or a pulling feeling around the wound is normal for a few days. You will get clear wound-care instructions, and stitches either dissolve or are removed within one to two weeks. Serious complications such as bleeding or infection are uncommon.
A lymph node biopsy is really the start of the diagnosis, not the end. The removed tissue goes through several layers of testing so that the exact subtype can be named — and the subtype is what decides treatment. CION runs this work-up directly.
The pathologist first examines the node's overall architecture under the microscope — the single biggest reason the whole node is preferred over loose cells.
Special stains detect proteins on the cells — markers such as CD20, CD30 and BCL2 — that identify the cell type. See how immunohistochemistry identifies your subtype.
Flow cytometry and immunophenotyping characterise the cell surface markers, and where needed, molecular and genetic testing looks at cell-of-origin and double-hit rearrangements (MYC, BCL2). Together these reveal exactly which lymphoma subtype you have. Blood markers such as LDH and results from routine blood tests add context but do not replace the tissue diagnosis. It all comes together in your pathology report.
A preliminary report may be ready in a few days, but a complete lymphoma diagnosis usually takes about one to two weeks because of these added tests. Difficult cases at CION are reviewed at a multidisciplinary tumour board. Figures and timelines vary by individual.
The biopsy does not decide the outlook on its own — the subtype and stage do. Across published series, Hodgkin lymphoma is often quoted at roughly 80–90% long-term survival and diffuse large B-cell lymphoma at roughly 60–70%, per NCCN and ESMO-referenced data. Figures vary by individual, so these are general guides rather than predictions for any one person. What a good biopsy makes possible is an accurate subtype diagnosis — which is exactly what lets the team match the right therapy. (Source: NCCN and ESMO lymphoma guidelines and published outcome series.)
Lymphoma diagnosis is nuanced, and a second opinion on the tissue is especially valuable in a few situations:
CION offers a dedicated, free written second-opinion service, and difficult cases go to our multidisciplinary tumour board. To take the next step, see our lymphoma doctors and lymphoma hospital in Hyderabad, request your free second opinion, or call 18002028726.
This page is part of our Diagnosis & Tests cluster. Each guide below explains one step in confirming and characterising lymphoma.
Get a free written second opinion from CION's lymphoma tumour board — especially valuable if only a needle sample was taken or the subtype is still unclear.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A lymph node biopsy is a procedure that removes a lymph node — or a piece of one — so a pathologist can examine it under the microscope and confirm whether lymphoma is present, and if so, which subtype. It is the single test that establishes a definitive diagnosis; scans and blood tests can raise suspicion but cannot confirm lymphoma on their own. For lymphoma, doctors strongly prefer removing the whole node (an excisional biopsy) because the architecture of the entire node carries diagnostic information. The sample then goes through detailed testing — including immunohistochemistry and flow cytometry — to pin down the exact diagnosis.
Lymphoma is diagnosed largely from the architecture of the lymph node — how the cells are arranged, not just what individual cells look like. A fine-needle aspiration (FNA) pulls out loose cells and destroys that architecture, so it is often not enough to diagnose lymphoma or to tell one subtype from another. NCCN and ESMO guidelines therefore recommend an excisional (whole-node) biopsy whenever lymphoma is suspected and a node is accessible. When surgery on a deep node is not practical, a core needle biopsy that takes tissue cores can be an acceptable alternative. Getting enough good tissue the first time avoids a repeat procedure and delays.
For a surface node in the neck, armpit or groin, an excisional biopsy is usually a short day-care procedure. Depending on the node and your health, it is done under local anaesthetic with sedation or under general anaesthetic. The surgeon makes a small incision, removes the whole node (or the largest accessible one), and closes with fine sutures. It typically takes 30 to 60 minutes and most people go home the same day. For a deep node in the chest or abdomen, an image-guided core needle biopsy under CT or ultrasound may be used instead. The removed tissue is sent fresh to the laboratory so that flow cytometry and molecular studies can be run alongside standard staining.
The biopsy itself should not hurt, because the area is numbed with local anaesthetic or you are asleep under general anaesthetic. Afterwards, mild soreness, bruising or a pulling sensation around the wound is common for a few days and is usually managed with simple pain relief. Most people return to light activity within a day or two, avoiding heavy lifting or vigorous exercise until the wound has healed. Stitches are removed or dissolve over one to two weeks. Serious complications — such as bleeding or infection — are uncommon. Your CION team will give clear wound-care instructions and a point of contact if you have any concerns while you recover.
A preliminary microscope report is often available within a few days, but a complete lymphoma diagnosis usually takes about one to two weeks. That is because confirming the subtype needs several layers of testing on the same tissue — immunohistochemistry for markers such as CD20 and CD30, flow cytometry, and sometimes molecular and genetic tests. This step-by-step work is what allows the exact subtype to be named accurately, which directly shapes treatment. The waiting period is understandably stressful; at CION, difficult or borderline cases are reviewed at a multidisciplinary tumour board so the final pathology report is as accurate as possible.
A lymph node biopsy is really the starting point for a panel of tests, all performed on the removed tissue. Standard staining shows the overall architecture; immunohistochemistry detects proteins such as CD20, CD30 and BCL2 that identify the cell type; flow cytometry and immunophenotyping characterise the cell surface markers; and, where needed, molecular and genetic testing looks at features such as cell-of-origin or double-hit rearrangements (MYC, BCL2). Together these reveal exactly which lymphoma subtype you have. Your consolidated pathology report brings all of this together into a single diagnosis that guides the treatment plan.
A biopsy does not make lymphoma worse or spread it — it simply gives your team the accurate diagnosis needed to treat it well, and many lymphomas respond very well to treatment. Across published series, outcomes vary by subtype and stage: Hodgkin lymphoma is often quoted at roughly 80–90% long-term survival, and diffuse large B-cell lymphoma at roughly 60–70%, per NCCN and ESMO-referenced data. Figures vary by individual, so these are general guides, not predictions for any one person. What the biopsy makes possible is a precise subtype diagnosis, which is exactly what lets the team match the right therapy. To discuss what your results mean for treatment, see Lymphoma Treatment in Hyderabad or book a free consultation.
Browse our complete guide to lymphoma — symptoms, diagnosis, Hodgkin and non-Hodgkin subtypes, treatment, genetics, prognosis, survivorship and cost. Tap any topic to read more.